A University of Virginia Center for Diabetes Technology-developed algorithm—paired with a continuous glucose monitor—can help users better manage their type 2 diabetes by recommending insulin-dose ...

Algorithm with glucose monitor improves insulin dosing and boosts time in safe blood sugar range in type 2 diabetes.

A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage ...

News and commentary from the endocrinology world ...

Adults with type 1 diabetes had an increase in total daily insulin dose and bolus insulin dose shortly after stopping semaglutide therapy, according to a speaker. As Healio previously reported, in a ...

Sen. Bernie Sanders recently conducted a policy interview with Claude, an AI assistant developed by Anthropic, which ...

MiniMed receives US FDA clearance of MiniMed Flex, the company's smallest insulin pump featuring its first smartphone-controlled design: Northridge, California Friday, March 20, 2 ...

Here's what to know about peptides, what they can and can't do, and what's driving viral claims about possible health benefits online.

David Beran and colleagues argue that the GLP-1 receptor agonists might not have been appropriate for addition to the 2025 WHO Essential Medicines List (EML) for three reasons.e First, the authors ...

At the Blue Jays’ player development complex, you may see prospect Aaron Parker walking around with a brown leather fanny ...